Soft tissue body composition during prevention and treatment of postmenopausal osteoporosis assessed by photon absorptiometry.
Hassager
C
C
Department of Clinical Chemistry, Glostrup Hospital.
D015502:Absorptiometry, Photon / Q000379:methods*; D045930:Anabolic Agents / Q000494:pharmacology / Q000627:therapeutic use; D000886:Anthropometry; D001823:Body Composition; D001834:Body Water; D015519:Bone Density / Q000187:drug effects; D003238:Connective Tissue / Q000737:chemistry*; D003404:Creatinine / Q000652:urine; D004594:Electrophysiology; D015914:Estrogen Replacement Therapy; D004967:Estrogens / Q000494:pharmacology; D005260:Female; D006801:Humans; D008593:Menopause / Q000502:physiology*; D010024:Osteoporosis / Q000503:physiopathology / Q000517:prevention & control*; D011188:Potassium / Q000032:analysis; D011374:Progesterone / Q000494:pharmacology
D045930:Anabolic Agents; D004967:Estrogens; D011374:Progesterone; D003404:Creatinine; D011188:Potassium